Published in Diabetes Res Clin Pract on May 01, 2005
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes Obes Metab (2013) 1.85
Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis. Open Med (2011) 1.41
Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis. PLoS One (2015) 0.93
Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis. Diabetologia (2013) 0.87
Comparative evaluation of incretin-based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure. J Diabetes Investig (2010) 0.80
Diabetes: glycaemic control in type 2. BMJ Clin Evid (2008) 0.78
Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis. Br J Clin Pharmacol (2016) 0.77
Observational and clinical trial findings on the comparative effectiveness of diabetes drugs showed agreement. J Clin Epidemiol (2014) 0.75
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med (1995) 4.29
Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise. Diabetes Obes Metab (2013) 3.88
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial. Diabetologia (2013) 2.67
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial. Int J Clin Pract (2013) 2.09
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care (1998) 1.58
Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int (2001) 1.45
Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract (1993) 1.38
The Xenopus oocyte as a surrogate secretory system. The specificity of protein export. Eur J Biochem (1980) 1.11
Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab (1985) 1.10
Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes. Am J Med (1987) 1.06
Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res (1983) 1.04
Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism (1996) 1.03
Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man. J Clin Invest (1995) 1.01
Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study. Am J Epidemiol (1995) 0.98
A pilot study analyzing PSA, serum testosterone, lipid profile, body mass index and race in a small sample of patients with and without carcinoma of the prostate. Prostate Cancer Prostatic Dis (2001) 0.98
Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones. Ann Intern Med (1985) 0.98
Estimation of glucose-alanine-lactate-glutamine cycles in postabsorptive humans: role of skeletal muscle. Am J Physiol (1995) 0.98
Thyroidal radioiodine uptake values in euthyroid subjects in Birmingham, Alabama. Ala J Med Sci (1969) 0.97
Differential impact of obesity on glucose metabolism in black and white American adolescents. Am J Med Sci (1998) 0.93
Empyema due to Salmonella typhimurium with underlying alveolar cell carcinoma. South Med J (1984) 0.92
Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care (1984) 0.89
The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X. Diabetes Care (1997) 0.88
Coexistence of diabetes mellitus, optic atrophy, and sensorineural deafness: case report. Ann Ophthalmol (1986) 0.88
Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study. J Clin Pharmacol (2000) 0.86
Do sociodemographics and economic status predict risks for type II diabetes in African Americans? Diabetes Educ (1997) 0.86
Facilities and resources for diabetes care at regional health facilities in southern Ghana. Diabetes Res Clin Pract (1998) 0.85
SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics. Diabetes Obes Metab (2008) 0.84
Regulation of platelet phosphorylase. Biochim Biophys Acta (1975) 0.84
The differential effects of body fat distribution on insulin and glucose metabolism during pregnancy. Am J Obstet Gynecol (1994) 0.83
Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study. Heart (2005) 0.83
Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med (1984) 0.83
Effects of acute running exercise on whole body insulin action in obese male SHHF/Mcc-facp rats. J Appl Physiol (1985) (1994) 0.82
Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus. Metabolism (2004) 0.82
Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM. Diabetes Care (1994) 0.81
Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with diabetes. Diabetes Obes Metab (2013) 0.81
Primary adrenal insufficiency manifesting as malignant lymphoma. Arch Intern Med (1983) 0.80
Glutamine and alanine metabolism in NIDDM. Diabetes (1996) 0.80
Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. J Clin Endocrinol Metab (1986) 0.80
Differential response between diabetes and stress-induced hyperglycaemia to algorithmic use of detemir and flexible mealtime aspart among stable postcardiac surgery patients requiring intravenous insulin. Diabetes Obes Metab (2011) 0.79
Hypoglycemia after successful pancreas transplantation in type I diabetic patients. Diabetes Care (1991) 0.79
From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis. Eur J Endocrinol (2009) 0.78
Regulation of gluconeogenesis by glutamine in normal postabsorptive humans. Am J Physiol (1997) 0.78
The glycemic response to meals with six different fruits in insulin-dependent diabetics using a home blood-glucose monitoring system. Am J Clin Nutr (1987) 0.78
Cardiovascular effects of aging. Interrelationships of aortic, left ventricular, and left atrial function. Herz (2001) 0.78
Enhanced hepatic extraction of estrogens used for replacement therapy. J Clin Endocrinol Metab (1986) 0.78
Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians. Diabetologia (2003) 0.78
Sequential metabolic studies of pancreas allograft function in type 1 diabetic recipients. Diabet Med (1992) 0.77
Significance of parental history of type 2 diabetes on insulin sensitivity and glucose effectiveness in obese nondiabetic offspring of African-American patients. Diabetes Care (1999) 0.77
Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am J Med (1985) 0.76
Caloric restriction mimetics: physical activity and body composition changes. J Gerontol A Biol Sci Med Sci (2001) 0.76
The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study. Metabolism (2003) 0.76
Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus. Ethn Dis (1998) 0.76
Adrenal insufficiency: relative, classical or critical? Acta Anaesthesiol Scand (2008) 0.75
In normal young men acute dopaminergic blockade does not impair free water excretion following a standard water load. Commun Psychopharmacol (1980) 0.75
Altered C-peptide/insulin molar ratios and glucose turnover rates after stimulation in nondiabetic offsprings of type II diabetic patients. Metabolism (1987) 0.75
The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patients. Diabet Med (1991) 0.75
Significance of spontaneous ketonuria and serum C-peptide levels in obese type II diabetic patients. Diabetes Care (1984) 0.75
Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch Intern Med (1986) 0.75
Predicting type II diabetes in persons at risk. Ann Intern Med (1990) 0.75
Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent. Am J Med Sci (1985) 0.75
Chronic hyponatremia associated with diabetic amyotrophy. Arch Intern Med (1986) 0.75
Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities. Ohio State Med J (1984) 0.75
Clinical evaluation of determinants of glycemic control. A new approach using serum glucose, C-peptide, and body mass indexes in type II diabetic patients. Arch Intern Med (1986) 0.75
The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in type 2 diabetic patients. Diabetologia (1986) 0.75
Cardiovascular risk factors in African-Americans with varying degrees of glucose intolerance. Diabetes Care (1999) 0.75
Pancreatic allograft function as assessed by IMX first-phase insulin assays. Transplant Proc (1994) 0.75
Pregnancy complicated by insulinoma. Am J Med Sci (1984) 0.75
Case report: defective beta and alpha cell regulation in patients with hyperinsulinemia and acanthosis nigricans. Am J Med Sci (1994) 0.75
The role of splanchnic glucose output in determining glycemic responses after mixed meal in type II diabetic patients and normal subjects. Pancreas (1987) 0.75
Pancreatic exocrine "burnout" following pancreas transplantation. Transplant Proc (1992) 0.75
Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care (1985) 0.75
Ambulatory and exercise-induced blood pressure responses in type I diabetic patients and normal subjects. Diabetes Res Clin Pract (1987) 0.75
Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. Am J Med (1984) 0.75
Abnormal retinal artery responses to stress in patients with type I diabetes. Am J Med (1985) 0.75
High dose intravenous, but not low dose subcutaneous, insulin-like growth factor-I therapy induces sustained insulin sensitivity in severely resistant type I diabetes mellitus. J Clin Endocrinol Metab (1994) 0.75